| ... |
Skip
navigation links
 |
... |
 |
Head,
Retrovirus Gene Expression Section
HIV
Drug Resistance Program
National Cancer Institute
NCI-Frederick, P.O. Box
B, Building 535
Frederick, MD 21702-1201
Phone: 301-846-5611
Fax:
301-846-6863
E-mail: derse@ncifcrf.gov
|
Dr. David Derse earned his Ph.D. in 1982 from the State University of New
York at Buffalo, studying inhibitors of herpesvirus and cellular DNA polymerases
in the laboratory of Dr. Yung-Chi Cheng. Dr. Derse did his postdoctoral
research on bovine leukemia virus gene regulation under the supervision of Dr.
James W. Casey at the Louisiana State University Medical Center. After joining
the National Cancer Institute in 1986 as a Senior Staff Fellow, Dr. Derse continued
research on the Tax and Rex proteins encoded by deltaretroviruses. In 1991,
he became a tenured Senior Investigator and extended his research into comparative
biochemical analyses of lentivirus Tat and Rev proteins. In 2004, Dr. Derse
joined the HIV Drug Resistance Program as Head of the Retrovirus Gene Expression
Section. He is also an Adjunct Professor in the Graduate Program in Genetics
at George Washington University in Washington, D.C. Dr. Derse currently
serves on the Editorial Board of Retrovirology and the Executive Committee of
the Center of Excellence in HIV/AIDS and Cancer Virology, Center for Cancer Research.
His current work focuses on the molecular mechanisms of HIV-1 and HTLV-1 infection
and replication.
Last
modified: 12 January 2009 | | ... |
|
